14 Results for "

Ceramide synthases

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "Ceramide synthases" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-N6719
CAS No.: 116355-83-0
Fumonisin B1 is a mycotoxin produced from Fusarium moniliforme. Fumonisin B1 is a potent inhibitor of sphingosine N-acyltransferase (ceramide synthase) and disrupts de novo sphingolipid biosynthesis. Fumonisin B1 is the most abundant and toxic fumonisin .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-12744
CAS No.: 491833-30-8
Purity:  99.57%
Research Areas:  

Metabolic Disease Cancer

Genz-123346 free base is an orally available inhibitor of glucosylceramide synthase. Genz-123346 blocks the conversion of ceramide to glucosylceramide (GL1) and inhibits GM1 with an IC50 of 14 nM .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-12744A
CAS No.: 943344-58-9
Research Areas:  

Metabolic Disease

Genz-123346 is a potent, orally available glucosylceramide synthase inhibitor. Genz-123346 blocks the conversion of ceramide to glucosylceramide (GL1) and inhibits GM1 with an IC50 value of 14 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-126015
CAS No.: 2748196-63-4
Purity:  ≥97.0%
Target:  

Acyltransferase

Research Areas:  

Metabolic Disease

P053 is a potent, non-competitive and selective ceramide synthase 1 (CerS1) inhibitor wirh an IC50 of 0.5 μM. P053 acts as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle. Whole-body adiposity regulator .
loading...
    loading...
Cat. No.: HY-N6723
CAS No.: 116355-84-1
Fumonisin B2 is a selective ceramide synthase inhibitor and carcinogenic mycotoxin with toxicity comparable to that of Fumonisin B1 (HY-N6719). Fumonisin B2 inhibits de novo sphingolipid biosynthesis by blocking the amide bond formation between fatty acids and dihydrosphingosine, which leads to a massive intracellular accumulation of free dihydrosphingosine, altered sphingosine levels, subsequent inhibition of cell proliferation, and induction of cell death. Fumonisin B2 is used to investigate the pathogenesis of diseases associated with Fusarium verticillioides contamination, including equine leukoencephalomalacia, porcine pulmonary edema syndrome, human esophageal cancer, and rat hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-W356117
CAS No.: 94885-03-7
C6 NBD Glucosylceramide is a glucosylceramide fluorescent derivative (Ex=466 nm, Em=535 nm). C6 NBD Glucosylceramide can be used to study the metabolism and internalization of glucosylceramide and also for the determination of glucosyl ceramide synthase activity .
loading...
    loading...
Cat. No.: HY-144267
CAS No.: 2597958-02-4
Purity:  98.62%
Glucosylceramide synthase-IN-2 (compound T-690) is a potent, brain-penetrant and orally active glucosylceramide synthase (GCS) inhibitor with IC50s of 15 nM and 190 nM for human GCS and mouse GCS, respectively.Glucosylceramide synthase-IN-2 exhibits noncompetitive type inhibition with C8-ceramide and UDP-glucose.Glucosylceramide synthase-IN-2 can be used for Gaucher's disease research .
loading...
    loading...
Cat. No.: HY-D1573
CAS No.: 114301-99-4
C6 NBD Phytoceramide is a fluorescently labeled short-chain ceramide analog that can be recognized by mammalian GlcCer synthase (GCS) .
loading...
    loading...
Cat. No.: HY-N6730
CAS No.: 145040-09-1
Synonyms: Aminopentol
Target:  

Apoptosis

Hydrolyzed Fumonisin B1 (Aminopentol) is the backbone and main hydrolysis product of the mycotoxin Fumonisin B1 (HY-N6719). Hydrolyzed Fumonisin B1 can weakly inhibit ceramide synthase .
loading...
    loading...
Cat. No.: HY-N6723S
CAS No.: 1217481-36-1
Fumonisin B2- 13C34 is the 13C labeled Fumonisin B2 (HY-N6723) . Fumonisin B2, a mycotoxin produced by Fusarium moniliforme in various grains, is a potent inhibitor of sphingosine N-acyltransferase (ceramide synthase) and disrupts de novo sphingolipid biosynthesis .
loading...
    loading...
Cat. No.: HY-N6719S
CAS No.: 1217458-62-2
Fumonisin B1- 13C34 is the 13C labeled Fumonisin B1 (HY-N6719) . Fumonisin B1 is a mycotoxin produced from Fusarium moniliforme. Fumonisin B1 is a potent inhibitor of sphingosine N-acyltransferase (ceramide synthase) and disrupts de novo sphingolipid biosynthesis. Fumonisin B1 is the most abundant and toxic fumonisin .
loading...
    loading...
Cat. No.: HY-175198
CAS No.: 2928129-57-9
Target:  

Acyltransferase Fungal

Research Areas:  

Infection

Cs-2d is a selective ceramide synthases Cer1 inhibitor. Cs-2d has potent inhibitory activity toward C. neoformans Cer1, while maintaining a low off-target effect on human hCerS1. Cs-2d has potent antifungal activity with the significant growth inhibition. Cs-2d can be used for invasive fungal infections research .
loading...
    loading...
Cat. No.: HY-133491
CAS No.: 1402702-76-4
Target:  

Acyltransferase

Research Areas:  

Metabolic Disease Cancer

ST1060 is a Ceramide synthase 2 (CerS2) inhibitor. ST1060 reduces the levels of long-chain dihydroceramide (dhCer) produced by CerS2 catalysis, with IC50 values of 63.6 μM and 61.3 μM for C24:0 and C24:1, respectively. ST1060 is applicable to the research of ceramide metabolism disorders and cervical cancer .
loading...
    loading...
Cat. No.: HY-183140
CAS No.: 1629992-28-4
Target:  

Acyltransferase Caspase

Research Areas:  

Cancer

DH20931 is a ceramide synthase 2 (CerS2) activator. DH20931 inhibits growth of cancer cells by inducing lipotoxic endoplasmic reticulum (ER) stress. DH20931 shows synergistic anti-tumor efficacy with Doxorubicin (HY-15142A). DH20931 can be used for the research of breast cancer .
loading...
    loading...
  • 1